Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can high-tech rehab help stroke survivors regain arm function?

NCT ID NCT07698405

Disease control Sponsor: Azienda Unita Sanitaria Locale di Piacenza Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study investigates whether a personalized, technology-based rehabilitation program can improve arm movement and function in people who have had a stroke. Participants will receive the technology-enhanced therapy three times a week for about a month, alongside standard care. The goal is to see if this approach leads to better recovery of arm control and strength.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
technology-based upper limb rehabilitation program
What this could lead to
If effective, this approach could offer a more personalized and effective way to regain arm movement after a stroke.
What could go wrong
This is a small, single-cohort study with no control group, so results may not be generalizable. The technology may not provide significant benefit over standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult PwS admitted to the Intensive Rehabilitation Unit at Fiorenzuola d'Arda hospital. Sampling will be consecutive and carried out on the basis of feasibility and the flow of admissions to the Clinical Unit, amounting to approximately 3-5 individuals per month. The study will include PwS who meet eligibility criteria at the time of recruitment and who are able to understand and provide informed consent to participate.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years; * First-ever unilateral ischemic or hemorrhagic stroke; * Presence of upper limb motor impairment; * Modified Ashworth Scale (MAS) \< 3; * Montreal Cognitive Assessment (MoCA) \> 24; * Medically stable and able to participate in an intensive rehabilitation programme; * Ability to understand and follow study procedures; * Written informed consent. Exclusion Criteria: * Diagnosis of severe aphasia, based on medical records, preventing participation; * Bilateral hemisphere lesions; * Severe and unstable medical conditions (e.g. untreated seizure, heart failure) that preclude participation in rehabilitation; * Other neurological and/or psychiatric diseases; * Recent and unstabilized upper limb fracture.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fiorenzuola d'Arda Hospital - AUSL Piacenza

    RECRUITING

    Fiorenzuola d'Arda, Piacenza, 29017, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.